Collegium Pharmaceutical, Inc. COLL Accrued Liabilities, Current
Accrued Liabilities, Current at other companies
Other financials
Where this comes from
Reported directly by Collegium Pharmaceutical, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.
The official record: Collegium Pharmaceutical, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Collegium Pharmaceutical, Inc.'s accrued liabilities, current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Collegium Pharmaceutical, Inc.'s accrued liabilities, current?
- Collegium Pharmaceutical, Inc. (COLL) reported accrued liabilities, current of $58.15M in Q1 2026.
- How has Collegium Pharmaceutical, Inc.'s accrued liabilities, current changed year-over-year?
- Collegium Pharmaceutical, Inc.'s accrued liabilities, current increased by 8.2% year-over-year, from $53.74M to $58.15M.
- What is the long-term trend for Collegium Pharmaceutical, Inc.'s accrued liabilities, current?
- Over 5 years (2020 to 2025), Collegium Pharmaceutical, Inc.'s accrued liabilities, current has grown at a 20.4% compound annual growth rate (CAGR), from $24.66M to $62.46M.